Cytokine Levels in Critically Ill Children With Severe Sepsis and Their Relation With the Severity of Illness and Mortality

Abstract

Objective:

To study the baseline cytokine levels and their relation with the severity of illness and mortality in critically ill children with severe sepsis.

Design:

Subgroup analysis of a randomized, double-blind, placebo-controlled trial.

Setting:

Pediatric intensive care unit of a tertiary level teaching hospital in India.

Patients:

Fifty children with severe sepsis aged 3 months to 12 years.

Material and Methods:

Blood was collected at admission for estimation of pro-inflammatory (interleukin 6 [IL-6], IL-12p70, IL-17, and tumor necrotic factor α [TNF-α]) and anti-inflammatory (IL-10 and transforming growth factor β1 [TGF-β1]) cytokines.

Primary Outcome:

To find out correlation between cytokine levels and severity of illness scores (Pediatric Risk of Mortality [PRISM] III score, Sequential Organ Failure Assessment [SOFA], and Vasoactive-Inotropic Score [VIS]).

Secondary Outcomes:

To compare cytokine levels among survivors and nonsurvivors.

Results:

Baseline pro-inflammatory cytokine levels (median [interquartile range]) were IL-6: 189 (35-285) pg/mL, IL-12p: 48 (28-98) pg/mL, IL-17: 240 (133-345) pg/mL, and TNF-α: 296 (198-430) pg/mL; anti-inflammatory cytokine levels were IL-10: 185 (62-395) pg/mL and TGF-β1: 204 (92-290) ng/mL. Pro-inflammatory cytokines showed positive correlation with PRISM III score: IL-6 (Spearman correlation coefficient, ρ = 0.273, P = .06), IL-12 (ρ = 0.367, P = .01), IL-17 (ρ = 0.197, P = .17), and TNF-α (ρ = 0.284, P = .05), and anti-inflammatory cytokines showed negative correlation: IL-10 (ρ = −0.257, P = .09) and TGF-β (ρ = −0.238, P = .11). Both SOFA and VIS also showed weak positive correlation with IL-12 (ρ = 0.32, P = .03 and ρ = 0.31, P = .03, respectively). Among nonsurvivors (n = 5), the levels of all the measured pro-inflammatory cytokines were significantly higher as compared to survivors, IL-6: 359 (251-499) pg/mL versus 157 (97-223) pg/mL, P < .0001, IL-12p70: 167 (133-196) pg/mL versus 66 (30-100) pg/mL, P < .0001, IL-17: 400 (333-563) pg/mL versus 237 (122-318) pg/mL, P = .009, and TNF-α: 409 (355-503) pg/mL versus 330 (198-415) pg/mL, P = .002, respectively.

Conclusion:

In critically ill children with severe sepsis, pro-inflammatory cytokines (especially IL-12p70) showed a weak positive correlation with severity of illness and were significantly higher among nonsurvivors.

Keywords

cytokines severe sepsis critical illness children PRISM III

Get full access to this article

View all access options for this article.

References

Weiss

Fitzgerald

Pappachan

, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147–1157.

Kaukonen

Bailey

Suzuki

Pilcher

Bellomo

. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308–1316.

Marshall

. Understanding the global burden of pediatric sepsis. Am J Respir Crit Care Med. 2015;191(10):1096–1098.

Giuliano

Jr Markovitz

Brierley

, et al. Comparison of pediatric severe sepsis managed in U.S. and European ICUs. Pediatr Crit Care Med. 2016;17(6):522–530.

Tan

Wong

Sultana

Koh

Jit

Mok

, et al. Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(4):352–362.

Kaur

Vinayak

Mittal

Kaushik

Aamir

. Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: a prospective observational study. Indian J Crit Care Med. 2014;18(7):437–441.

Bateman

Seed

. Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy. Pediatrics. 2010;126(1):137–150.

Bozza

Salluh

Japiassu

, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49.

Mera

Tatulescu

Cismaru

, et al. Multiplex cytokine profiling in patients with sepsis. APMIS. 2011;119(2):155–163.

10.

Wong

Weiss

Giuliano

Jr Wainwright

Cvijanovich

Thomas

, et al. The temporal version of the pediatric sepsis biomarker risk model. PLoS One. 2014;9(3):e92121.

11.

Carlton

McHugh

McDonough

Sturza

Desch

Cornell

. Markers of endothelial dysfunction and cytokines in high-risk pediatric patients with severe sepsis. Am J Respir Crit Care Med. 2020;201(3):380–384.

12.

Wong

Salisbury

Xiao

, et al. The pediatric sepsis biomarker risk model. Crit Care. 2012;16(5):R174.

13.

Tamayo

Fernandez

Almansa

, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw. 2011;22(2):82–87.

14.

Gogos

Drosou

Bassaris

Skoutelis

. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181(1):176–180.

15.

Hackett

Thomson

Hart

. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol. 2001;50(10):847–859.

16.

Dinarello

. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112(6 suppl):321S–329S.

17.

Vardas

Ilia

Sertedaki

, et al. Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality. Intensive Care Med Exp. 2017;5(1):10.

18.

Fitrolaki

Dimitriou

Venihaki

Katrinaki

Ilia

Briassoulis

. Increased extracellular heat shock protein 90alpha in severe sepsis and SIRS associated with multiple organ failure and related to acute inflammatory-metabolic stress response in children. Medicine (Baltimore). 2016;95(35):e4651.

19.

Hamano

Gohra

Noda

, et al. Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. World J Surg. 1998;22(10):1077–1081.

20.

Panacek

Marshall

Albertson

, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab’)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004;32(11):2173–2182.

21.

Heper

Akalin

Mistik

, et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis. 2006;25(8):481–491.

22.

Rivers

Kruse

Jacobsen

, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med. 2007;35(9):2016–2024.

23.

Andaluz-Ojeda

Bobillo

, et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2012;57(3):332–336.

24.

Tschaikowsky

Hedwig-Geissing

Braun

Radespiel-Troeger

. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care. 2011;26(1):54–64.

25.

Hotchkiss

Moldawer

Opal

Reinhart

Turnbull

Vincent

. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.

26.

Wong

Cvijanovich

Wheeler

, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med. 2008;178(3):276–282.

27.

Nowak

Wheeler

Harmon

Wong

. Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock. Pediatr Crit Care Med. 2010;11(2):213–216.

28.

Vermont

Hazelzet

de Kleijn

van den Dobbelsteen

de Groot

. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit Care. 2006;10(1):R33.

29.

Angurana

Bansal

Singhi

, et al. Evaluation of effect of probiotics on cytokine levels in critically ill children with severe sepsis: a double-blind, placebo-controlled trial. Crit Care Med. 2018;46(10):1656–1664.

30.

Dellinger

Levy

Rhodes

, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

31.

Pollack

Patel

Ruttimann

. PRISM III: an updated pediatric risk of mortality score. Crit Care Med. 1996;24(5):743–752.

32.

Vincent

de Mendonca

Cantraine

, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800.

33.

McIntosh

Tong

Deakyne

Davidson

Scott

. Validation of the Vasoactive-Inotropic Score in pediatric sepsis. Pediatr Crit Care Med. 2017;18(8):750–757.

34.

Wernovsky

Wypij

Jonas

, et al.

Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest

. Circulation. 1995;92(8):2226–2235.

35.

Saharan

Lodha

Kabra

. Management of acute lung injury/ARDS. Indian J Pediatr. 2010;77(11):1296–1302.

36.

Jindal

Singhi

. Non-traumatic coma and altered mental status. Indian J Pediatr. 2012;79(3):367–375.

37.

Watson

Carcillo

. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med. 2005;6(3 suppl):S3–S5.

38.

Hua

Lin

Lai

Kong

Chang

Chen

. Probiotic bio-three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells. WJG. 2010;16(28):3529–3540.

39.

Wunder

Eichelbronner

Roewer

. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res. 2004;53(4):158–163.

40.

Monneret

Finck

Venet

, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett. 2004;95(2):193–198.

41.

Adib-Conquy

Cavaillon

. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009;101(1):36–47.

42.

Chiche

Forel

Thomas

, et al. The role of natural killer cells in sepsis. J Biomed Biotechnol. 2011;2011:986491.